Biontech: Vaccine has high efficacy in adolescents
Vaccine manufacturer Biontech has good news. According to a - yet unpublished - study, the vaccine works well with adolescents 12 to 16 years old.
Dieses YouTube-Video kann in einem neuen Tab abgespielt werden
YouTube öffnenThird party content
We use YouTube to embed content that may collect data about your activity. Please review the details and accept the service to see this content.
Open consent form